Mélanie Casile

Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)

Émilie Thivat, Mélanie Casile, J. Moreau et al. · BMC Cancer · 2023 · 62 citations · Full text

Medicine, Oncology, Pharmacology +17

Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers

Maureen Bernadach, M. Lapeyre, Anne-Françoise Dillies et al. · BMC Cancer · 2021 · 28 citations · Full text

Medicine, Oncology, Cancer Drug Toxicity Management +8

Preoperative stereotactic radiosurgery for brain metastases: the STEP study protocol for a multicentre, prospective, phase-II trial

Angeline Ginzac, G. Dupic, L. Brun et al. · BMC Cancer · 2021 · 13 citations · Full text

Medicine, Neurosurgery, Surgery +14

Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors

Brice Leyrat, Toufic Khalill, Jean‐Jacques Lemaire et al. · Clinical and Translational Radiation Oncology · 2022 · 12 citations · Full text

Medicine, Oncology, Radiation Oncology +17